A detailed history of Scarborough Advisors, LLC transactions in Organon & Co. stock. As of the latest transaction made, Scarborough Advisors, LLC holds 13 shares of OGN stock, worth $249. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13
Previous 16 18.75%
Holding current value
$249
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$17.45 - $21.96 $52 - $65
-3 Reduced 18.75%
13 $0
Q1 2024

May 10, 2024

SELL
$13.78 - $18.8 $27 - $37
-2 Reduced 11.11%
16 $0
Q4 2023

Feb 29, 2024

SELL
$10.95 - $17.32 $1,543 - $2,442
-141 Reduced 88.68%
18 $0
Q4 2023

Feb 22, 2024

BUY
$10.95 - $17.32 $1,741 - $2,753
159 New
159 $2,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.88B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Scarborough Advisors, LLC Portfolio

Follow Scarborough Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scarborough Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scarborough Advisors, LLC with notifications on news.